Bio-Rad Laboratories (BIO-B) Interest Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Interest Expenses data on file, last reported at $12.3 million in Q1 2026.

• Quarterly Interest Expenses rose 2.5% year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.3 million (up 1.44% YoY) and the FY2025 annual result came in at $49.0 million, changed 0.2% from the prior year.
• Interest Expenses rose to $12.3 million in Q1 2026 per BIO-B's latest filing, from $12.1 million in the prior quarter.
• Across five years, Interest Expenses topped out at $12.6 million in Q2 2025 and bottomed at $4.0 million in Q1 2022.
• The 5-year median for Interest Expenses is $12.3 million (2024), against an average of $11.6 million.
• The widest annual swing landed in 2022, when Interest Expenses jumped 3105.77%; it then fell 2.44% in 2025.
• Tracing BIO-B's Interest Expenses over 5 years: stood at $11.7 million in 2022, then advanced by 5.6% to $12.3 million in 2023, then slipped by 0.99% to $12.2 million in 2024, then retreated by 0.82% to $12.1 million in 2025, then increased by 1.65% to $12.3 million in 2026.
• Per Business Quant, the three latest BIO-B Interest Expenses figures stand at $12.3 million (Q1 2026), $12.1 million (Q4 2025), and $12.3 million (Q3 2025).

Peer Comparison